PARP inhibitors: the journey from research hypothesis to clinical approval
PARP inhibitors: the journey from research hypothesis to clinical approval
About this item
Full title
Author / Creator
Publisher
England: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
Cancer puts an increasing burden on our healthcare system and is a major cause of death. Therefore, novel approaches are required to improve cancer treatment. Cancer cells have several hallmarks that could be therapeutically targeted. Importantly, every tumor has a different combination of aberrations affecting the different hallmarks. This review...
Alternative Titles
Full title
PARP inhibitors: the journey from research hypothesis to clinical approval
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2038711582
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2038711582
Other Identifiers
ISSN
1741-0541
E-ISSN
1744-828X
DOI
10.2217/pme.14.71
